Sullivan, Maria A.

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial

Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 348

Attention Deficit/Hyperactivity Disorder and Substance Abuse: Diagnostic and Therapeutic Considerations

SULLIVAN, M. A., & RUDNIK‐LEVIN, F. (2001) · Annals of the New York Academy of Sciences

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 172

Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.

Levin, F. R., Mariani, J. J., Pavlicova, M., Brooks, D., Glass, A., Mahony, A., Nunes, E. V., Bisaga, A., Dakwar, E., Carpenter, K. M., et al. (2016) · Drug and Alcohol Dependence

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 109

A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.

Levin, F. R., Mariani, J., Brooks, D. J., Pavlicova, M., Nunes, E. V., Agosti, V., Bisaga, A., Sullivan, M. A., & Carpenter, K. M. (2013) · Addiction

Cannabis and Cannabinoid ResearchTreatment of Major Depression

Cited by 89